Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia.
Launched by FEDERAL TEACHING HOSPITAL ABAKALIKI · Nov 8, 2023
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
Background: Preeclampsia/eclampsia is part of a spectrum of multi-systemic pregnancy disorder that contributes substantially to maternal and perinatal morbidity and mortality, especially in low resource setting. This study was done in Abakaliki, Ebonyi State, Southeast Nigeria.
Objectives: To compare the efficacy of loading dose of magnesium sulphate with that of the Pritchard regimen in the prevention of eclampsia in patients with severe preeclampsia and recurrent fits in eclampsia in a low resource setting like ours.
Methods: This was a prospective, single blinded randomized controlled ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women with severe preeclampsia
- • Pregnant women with eclampsia
- • Signing of informed consented to participate in the study.
- Exclusion Criteria:
- • Refusal of consent,
- • Gestational age \< 28 weeks
- • Received magnesium sulphate prior to presentation
- • mild preeclampsia
- • chronic hypertension in pregnancy
- • Medical or Obstetrical complication of pregnancy.
About Federal Teaching Hospital Abakaliki
Federal Teaching Hospital Abakaliki is a leading healthcare institution dedicated to providing comprehensive medical services, education, and research. As a clinical trial sponsor, the hospital is committed to advancing medical knowledge and improving patient care through innovative research initiatives. With a focus on ethical practices and patient safety, the hospital collaborates with various stakeholders to conduct clinical trials that address pressing health challenges. Its multidisciplinary team of healthcare professionals and researchers leverages state-of-the-art facilities to facilitate groundbreaking studies, ultimately contributing to the enhancement of evidence-based medicine and public health outcomes in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Abakaliki, Ebonyi, Nigeria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported